Clinical Convergence®: Creating a Framework for Personalized Management in the Treatment of Children with Asthma

Proprietary Educational Format:

Activity Overview

An Online IME Intervention Featuring Clinician and Patient Faculty and a Decision Support Aid for Practice Application Experts in the management of children with asthma discuss the origins of this disorder, challenges associated with the management of this population, current management guidelines, and the role of biologic therapy in the treatment of individual patients. Conversations with two pediatric patients with asthma and their parents are included to provide a real-world perspective on the management of this disease.

0.50 CE Credit(s)
Expires: November 12, 2021

Target Audience

This activity is designed for clinicians (MD/DO, NP, PA) practicing in the specialties of allergy/immunology, pediatrics, and pulmonology, who diagnose and manage asthma in children.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Identify barriers to the optimal management of children with asthma
  • Apply established guidelines and algorithms when managing children with asthma
  • Assess current data on approved and emerging biologic therapies for the treatment of children with asthma
  • Recognize that children with moderate-to-severe asthma may benefit from treatment with a biologic therapy

Activity Faculty

Jonathan Corren, MD

Jonathan Corren, MD

Associate Clinical Professor, Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Michael E. Wechsler, MD, MMSc

Michael E. Wechsler, MD, MSSc

Professor, Medicine
Director, Cohen Family NJH Asthma Institute
Director, Asthma Program, National Jewish Health
Division of Pulmonary, Critical Care and Sleep Medicine
Department of Medicine
National Jewish Health and University of Colorado School of Medicine
Aurora, CO